New Drug Could Transform Pancreatic Cancer Treatment
May 18, 2015 at 14:16 PM EDT
Halozyme Therapeutics, Inc. (NASDAQ: HALO) has developed a new drug called PEGPH 20, which is changing the way pancreatic cancer ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.